![](https://investorshub.advfn.com/uicon/102211.png?cb=1719302007)
Monday, September 15, 2008 11:44:01 AM
The facts:
Biophan's management are allegedly well on their way to getting the float increased to 800 million shares, representing MegaDilution of 357%.
We know from past history and the DEF 14A filing that they will not hesitate to use these shares to pay the "sewer rats", even though they have $5.6 million cash they couild buy shares with in the open market, obviating the need for further dilution and increasing the value of the outstanding shares at a stroke.
No further news on Myotech CSS, except Ms. Hotchkiss' comment in a recent shareholder communication that it remains "24-36 months from commercialization", as it has been for the past several years.
Something not quite right here.
I wonder what it is?
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM